SCHEMBL9853429

SCHEMBL9853429

CN1C(=O)c2ccccc2Oc2ncccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
TP53 P04637 2/20 0.44
TTR P02766 1/20 0.44
CES1 P23141 1/20 0.44
BRD4 O60885 1/20 0.43
MAPK7 Q13164 1/20 0.43
HTT P42858 2/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
CASP1 P29466 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9102280 0.88 TP53 (0.52) NR1H2NR1H3TP53TTRCES1
SCHEMBL8936687 0.82 NR1H2 (0.44) NR1H2NR1H3TP53BRD4LMNA
SCHEMBL9853427 0.79 TP53 (0.48) TP53LMNASMN1; SMN2ALDH1A1POLB
SCHEMBL14288741 0.79 NR1H2 (0.58) NR1H2NR1H3TTRCES1BRD4
SCHEMBL8936669 0.78 TP53 (0.46) TP53LMNASMN1; SMN2POLBTDP1
SCHEMBL8936648 0.77 TP53 (0.45) TP53LMNASMN1; SMN2ALDH1A1POLB
SCHEMBL8936730 0.77 TP53 (0.53) TP53ALDH1A1POLBKMT2AMAPT
SCHEMBL8936654 0.77 TP53 (0.45) TP53LMNASMN1; SMN2ALDH1A1POLB
SCHEMBL16065742 0.75 MAPK7 (0.45) NR1H2NR1H3TTRCES1BRD4
SCHEMBL9101978 0.75 MAPT (0.53) LMNASMN1; SMN2POLBKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417534-A1 Pyrido[2,3-b][1,4]benzoxazepin (and thiazepin)-6(5H)-ones and thiones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1991-03-20 EP disclosed